Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTS (Daytrana) wear times in pediatric ADHD
NCT00151970Phase 2Completed
- Sponsor
- Noven Therapeutics, LLC
- Start
- Jun 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Noven Therapeutics, LLC. Primary endpoint: SKAMP deportment rating scale at Week 8. Started Jun 2005; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00151970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151970.